📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial (2022)

First Author: Watson-Jones Deborah
Attributed to:  A Dose Reduction Immunobridging Study of two HPV vaccines in Tanzanian girls funded by GCRF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2214-109x(22)00309-6

Publication URI: http://dx.doi.org/10.1016/s2214-109x(22)00309-6

Type: Journal Article/Review

Volume: 10

Parent Publication: LANCET GLOBAL HEALTH

Issue: 10

ISSN: 2214-109X